Research ArticleNuclear Oncology
Prediction of Survival with Fluorine-18-Fluoro-deoxyglucose and PET in Head and Neck Cancer
Heikki Minn, Maria Lapela, Pekka J. Klemi, Reidar Grénman, Sirkku Leskinen, Paula Lindholm, Jörgen Bergman, Esa Eronen, Merja Haaparanta and Heikki Joensuu
Journal of Nuclear Medicine December 1997, 38 (12) 1907-1911;
Heikki Minn
Maria Lapela
Pekka J. Klemi
Reidar Grénman
Sirkku Leskinen
Paula Lindholm
Jörgen Bergman
Esa Eronen
Merja Haaparanta
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Prediction of Survival with Fluorine-18-Fluoro-deoxyglucose and PET in Head and Neck Cancer
Heikki Minn, Maria Lapela, Pekka J. Klemi, Reidar Grénman, Sirkku Leskinen, Paula Lindholm, Jörgen Bergman, Esa Eronen, Merja Haaparanta, Heikki Joensuu
Journal of Nuclear Medicine Dec 1997, 38 (12) 1907-1911;
Prediction of Survival with Fluorine-18-Fluoro-deoxyglucose and PET in Head and Neck Cancer
Heikki Minn, Maria Lapela, Pekka J. Klemi, Reidar Grénman, Sirkku Leskinen, Paula Lindholm, Jörgen Bergman, Esa Eronen, Merja Haaparanta, Heikki Joensuu
Journal of Nuclear Medicine Dec 1997, 38 (12) 1907-1911;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Metabolic Phenotypes, Dependencies, and Adaptation in Lung Cancer
- Addition of 18F-FDG PET/CT to Clinical Assessment Predicts Overall Survival in HNSCC: A Retrospective Analysis with Follow-up for 12 Years
- Prognostic Value of Preoperative Metabolic Tumor Volume and Total Lesion Glycolysis Measured by 18F-FDG PET/CT in Salivary Gland Carcinomas
- Prognostic Ability of 18F-FDG PET/CT in the Assessment of Colorectal Liver Metastases
- Oesophageal squamous cell carcinoma: relationship between fluorine-18 fludeoxyglucose positron emission tomography CT maximum standardised uptake value, metabolic tumour volume, and tumour, node and metastasis classification
- Prediction of Disease-Free Survival in Patients with Squamous Cell Carcinomas of the Head and Neck Using Dynamic Contrast-Enhanced MR Imaging
- Use of 18F-FDG PET for Primary Treatment Strategy in Patients with Squamous Cell Carcinoma of the Oropharynx
- Clinical Utility of 18F-FDG PET for Patients with Salivary Gland Malignancies
- Prediction of Survival and Therapy Outcome with 11C-Tyrosine PET in Patients with Laryngeal Carcinoma
- Nuclear medicine in imaging head and neck malignancies
- Standardized Uptake Value of 2-[18F] Fluoro-2-Deoxy-D-Glucose in Predicting Outcome in Head and Neck Carcinomas Treated by Radiotherapy With or Without Chemotherapy